Cargando…

Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer

The integral role of positron-emission tomography (PET) using the glucose analog tracer fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) is well established. Evidence is emerging for the role of PET in response assessment to neoadjuvant therapy, combined-moda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuaron, John, Dunphy, Mark, Rimner, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539654/ https://www.ncbi.nlm.nih.gov/pubmed/23316478 http://dx.doi.org/10.3389/fonc.2012.00208

Ejemplares similares

Impact of Renal Failure on F18-FDG PET/CT Scans
por: Kode, Vishwajit, et al.
Publicado: (2017)

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
por: Feng, Pengyang, et al.
Publicado: (2022)

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
por: Lee, Sze Ting, et al.
Publicado: (2021)

A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer
por: Zhou, Jianyuan, et al.
Publicado: (2021)

Correlation Between Dual-Time-Point FDG PET and Tumor Microenvironment Immune Types in Non-Small Cell Lung Cancer
por: Zhou, Jianyuan, et al.
Publicado: (2021)

Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
por: Calabrese, Cecilia, et al.
Publicado: (2016)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

(18)F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer
por: Qiao, Jianyi, et al.
Publicado: (2022)

Multidisciplinary Postoperative Validation of (18)F-FDG PET/CT Scan in Nodal Staging of Resected Non-Small Cell Lung Cancer
por: Bedetti, Benedetta, et al.
Publicado: (2022)

S‐100B as an extra selection tool for FDG PET/CT scanning in follow‐up of AJCC stage III melanoma patients
por: Deckers, Eric A., et al.
Publicado: (2019)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
por: Wu, Junhao, et al.
Publicado: (2022)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer
por: Wumener, Xieraili, et al.
Publicado: (2022)

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging
por: Alhusaini, Saud, et al.
Publicado: (2023)

Habitat Imaging-Based (18)F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases
por: Chen, Ling, et al.
Publicado: (2021)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

Validation of nonrigid registration in pretreatment and follow‐up PET/CT scans for quantification of tumor residue in lung cancer patients
por: Spijkerman, Jolanda, et al.
Publicado: (2014)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy
por: Takeda, Kazuya, et al.
Publicado: (2017)

Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands
por: Gertsen, Emma C., et al.
Publicado: (2020)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada
por: Beers, Craig A., et al.
Publicado: (2023)

Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021)

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma
por: Fu, Zheng, et al.
Publicado: (2022)

Active Shingles Infection as Detected on (18)F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2013)

Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies
por: Zeng, Feibi, et al.
Publicado: (2020)

Development and Validation of a (18)F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal–Hilar Lymph Nodes in Non-Small-Cell Lung Cancer
por: Ouyang, Ming-li, et al.
Publicado: (2021)

Predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer
por: Shang, Jingjie, et al.
Publicado: (2022)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients
por: Assi, Hazem I., et al.
Publicado: (2021)

Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery
por: Amini, Arya, et al.
Publicado: (2012)

Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up
por: Baak, Jan P. A., et al.
Publicado: (2022)

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer
por: Lee, Percy, et al.
Publicado: (2012)

Effects of cigarette smoking on metabolic activity of lung cancer on baseline (18)F-FDG PET/CT
por: Jiang, Maoqing, et al.
Publicado: (2022)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

Prospective comparison of (68)Ga-FAPI-04 and (18)F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
por: Ding, Haoyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u1hvef27fc15a9alusp6qtrs0q